All In Biotech

Free tool

FAERS Monitor: Oxderys

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 221093 or its brand name (Oxderys, Doxorubicin Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

26,045

Serious

24,961

96% of reports

Hospitalization

10,285

Death reported

4,432

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use3,556
  • febrile neutropenia3,192
  • neutropenia1,978
  • product use in unapproved indication1,597
  • disease progression1,570
  • pyrexia1,559
  • anaemia1,264
  • nausea1,254
  • thrombocytopenia1,093
  • vomiting1,048
  • diarrhoea975
  • drug ineffective892
  • pneumonia891
  • sepsis869
  • white blood cell count decreased858

Reports by year received

View as table
YearReports
2004153
2005198
2006192
2007375
2008386
2009161
2010206
2011407
2012594
2013512
2014396
2015796
2016861
20171,028
20181,288
20191,453
20202,114
20211,729
20222,983
20233,234
20242,877
20252,351
20261,751

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,114 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
white blood cell count decreasedSignal8586.46.03,922
sepsisSignal8696.35.93,888
anaemiaSignal1,2645.45.14,515
product use in unapproved indicationSignal1,5975.25.05,490
pyrexiaSignal1,5593.73.53,034
off label useSignal3,5563.33.25,884
pneumoniaSignal8912.22.1608
vomiting1,0481.81.7381
nausea1,2541.31.279
diarrhoea9751.21.140
drug ineffective8920.50.5358
febrile neutropenia3,1920.00.02,576,727
neutropenia1,9780.00.01,596,332
disease progression1,5700.00.01,266,867
thrombocytopenia1,0930.00.0881,700

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.